Clinical trial
ACC - Atrial Contribution to CRT
NCT00180323 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00180323 |
|---|---|
| Title | ACC - Atrial Contribution to CRT |
| Official title | ACC - Atrial Contribution to CRT |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Dilated Cardiomyopathy |
| Intervention type | Device |
| Interventions | Renewal |
| Enrollment | 43 |
| Start date | Nov 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 11, 2021 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: